Quantics Biostatistics
Quantics Biostatistics, a leading name in the biostatistics industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2015, the company has quickly established itself as a trusted partner for pharmaceutical and biotechnology firms, providing expert statistical consulting and data analysis services. Specialising in clinical trial design, statistical programming, and data management, Quantics Biostatistics stands out for its commitment to delivering tailored solutions that meet the unique needs of each client. The firm’s innovative approach and rigorous methodologies have garnered recognition, positioning it as a key player in the biostatistics landscape. With a focus on enhancing the efficiency and accuracy of clinical research, Quantics Biostatistics continues to achieve significant milestones, contributing to advancements in healthcare and improving patient outcomes globally.
DitchCarbon Score
How does Quantics Biostatistics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quantics Biostatistics's score of 9 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Quantics Biostatistics's reported carbon emissions
Quantics Biostatistics, headquartered in the United Kingdom, has set ambitious climate commitments despite not having specific carbon emissions data available. The company is committed to maintaining zero Scope 1 emissions through 2030, demonstrating a strong focus on direct emissions reduction. Additionally, Quantics aims to reduce its absolute Scope 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi), aligning with the necessary reductions to limit global warming to 1.5°C. Furthermore, Quantics is dedicated to measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. These commitments reflect the company's proactive approach to sustainability and its recognition of the importance of addressing climate change within the professional services sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quantics Biostatistics is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
